Literature DB >> 22988648

Nonpseudomonal ecthyma gangrenosum associated with methicillin-resistant staphylococcus aureus infection: a case report and review of the literature.

Aileen Y Chang1, Casey A Carlos, Mindy Schuster, Xiaowei Xu, Misha Rosenbach.   

Abstract

Ecthyma gangrenosum (EG) is a skin infection that is classically associated with Pseudomonas aeruginosa septicemia in immunocompromised patients. Other bacterial, viral, and fungal pathogens also have been implicated in EG. Both bacteremic and nonbacteremic forms of EG have been described. We describe a case of EG associated with methicillin-resistant Staphylococcus aureus (MRSA) in a 35-year-old woman with acute lymphoblastic leukemia (ALL) and review the literature.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22988648

Source DB:  PubMed          Journal:  Cutis        ISSN: 0011-4162


  5 in total

1.  Ecthyma gangrenosum caused by Citrobacter freundii.

Authors:  Tyson Hawkley; David Chang; Whitney Pollard; David Ferraro
Journal:  BMJ Case Rep       Date:  2017-07-27

2.  Ecthyma gangrenosum secondary to methicillin-sensitive Staphylococcus aureus.

Authors:  Jurate Ivanaviciene; Lisa Chirch; Jane M Grant-Kels; Philip E Kerr; Justin Finch
Journal:  Int J Womens Dermatol       Date:  2016-07-22

3.  Ecthyma Gangrenosum Secondary to Methicillin-Sensitive Staphylococcus aureus in an Atopic Child with Transient Neutropenia: A Case Report and Review of the Literature.

Authors:  Ko-Chun Fang; Fang-Ju Lin; Chih-Ho Chen; Yi-Ning Huang; Jui Lan; Han-Chi Tseng; Yi-Chuan Huang
Journal:  Diagnostics (Basel)       Date:  2022-07-11

Review 4.  Ecthyma gangrenosum caused by Staphylococcus aureus in hematological malignancies: Case reports and literature review.

Authors:  Yuka Kudo Nagata; Noritaka Sekiya; Kazuaki Fukushima; Masao Horiuchi; Noriko Doki
Journal:  Medicine (Baltimore)       Date:  2022-08-19       Impact factor: 1.817

5.  Nonpseudomonal ecthyma gangrenosum of the upper lid treated with lid reconstruction.

Authors:  S Praveen Kumar; K V Praveen Kumar; Subashini Kaliaperumal; Arjun Ashokan
Journal:  Indian J Ophthalmol       Date:  2015-10       Impact factor: 1.848

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.